Cited by 88Dementia and Cognitive Impairment ResearchCerebrovascular and genetic disordersAlzheimer's disease research and treatments

Frontal lobe white matter hyperintensities and neurofibrillary pathology in the oldest old

Open access
Polvikoski, T.M., van Straaten, E.C.W., Barkhof, F., Sulkava, R., Aronen, H.J., Niinistö, L., Oinas, M., Scheltens, P. +2 more·2010·Neurology

Abstract

BACKGROUND: Current studies suggest an interaction between vascular mechanisms and neurodegenerative processes that leads to late-onset Alzheimer disease (AD). We tested whether AD pathology was associated with white matter hyperintensities (WMH) or cerebral infarcts in the oldest old individuals. METHODS: Brains from 132 subjects over 85 years old, who came to autopsy from the Vantaa 85+ population-based cohort, were scanned by postmortem MRI and examined for neuropathologic changes. Coronal images were analyzed to determine the degree of frontal and parietal periventricular WMH (PVWMH) and deep WMH (DWMH) and cerebral infarcts. Neuropathologic variables included Consortium to Establish a Registry for Alzheimer's Disease scores for neuritic plaques and Braak staging among subjects in 5 groups: normal aging (NA), borderline with insufficient AD pathology, AD, AD plus other pathology, and other primary degenerative diseases. RESULTS: Frontal DWMH were detected in >50% of the sample. Both frontal PVWMH and DWMH were significantly more extensive in the AD group compared to the NA group or the NA and borderline groups combined. Frontal PVWMH and DWMH were also associated with increased Braak staging (p = 0.03) and the neuritic plaque load (p = 0.01). Further analysis revealed there were a greater number of cerebral infarcts associated with frontal DWMH (p = 0.03) but not with frontal PVWMH. CONCLUSIONS: Our study showed an association between neurofibrillary pathology and frontal PVWMH and DWMH (rather than parietal), as a surrogate of small vessel disease, particularly in very old community-dwelling individuals.

Integrity signals

Registry

Crossref · 10.1212/wnl.0b013e318200d6f9

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The citation lists haven’t been fetched yet

References 41 · Cited by 88

Authors
Polvikoski, T. M., van Straaten, E. C. W., Barkhof, F., Sulkava, R., Aronen, H. J., Niinistö, L., Oinas, M., Scheltens, P., Erkinjuntti, T., & Kalaria, R. N.
Affiliations
  • University of Turku (FI)
  • From the Institute for Ageing and Health (T.M.P., R.N.K.), Newcastle University, Newcastle upon Tyne, UK; Departments of Neurology (E.C.W.v.S., P.S.) and Radiology (F.B.), VU University Medical Centre, Amsterdam, the Netherlands; Department of Community Health and General Practice (R.S.), University of Kuopio, Kuopio; Department of Radiology (H.J.A.), Turku University Central Hospital and University of Turku, Turku; Katriina Hospital (L.N.), Vantaa; Departments of Neurosurgery and Pathology (M.O.),...
Venue
Neurology
Published
2010-12-07
Volume
75
Issue
23
Pages
2071-2078
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W1998886798
Cited by
88
References
41
Citations by year
2026: 1 · 2025: 3 · 2024: 3 · 2023: 3 · 2022: 4 · 2021: 4 · 2020: 3 · 2019: 4 · 2018: 6 · 2017: 4 · 2016: 9 · 2015: 6 · 2014: 12 · 2013: 9 · 2012: 10
FWCI
5.67
Type
journal article
Language
en
Open access
Locations
  • Neurology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • Pure Amsterdam UMC (submittedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • Newcastle University ePrints (Newcastle Univesity)
Funders
  • Danone
  • Alzheimer Nederland
  • H. Lundbeck A/S
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Neurology › Cerebrovascular and genetic disorders
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
Keywords
white matter hyperintensities, neurofibrillary pathology, Alzheimer's disease, oldest old, cerebral infarction, cerebral small vessel disease, Braak staging, neuritic plaques, periventricular white matter hyperintensities, deep white matter hyperintensities, vascular risk factors, postmortem MRI, neuropathology
MeSH terms
Aged, 80 and over, Aging, Alzheimer Disease, Cerebral Ventricles, Female, Frontal Lobe, Humans, Magnetic Resonance Imaging, Male, Myelin Sheath, Postmortem Changes, Cohort Studies, Chi-Square Distribution, Neurofibrillary Tangles, Brain Infarction, alpha-Synuclein, Plaque, Amyloid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review